IMAGE GALLERY:
Spotlight on In Silico Evidence at AAD 2024: International Affairs Working Group Session
28/08/2024
BACK
At AAD 2024, the International Affairs Working Group will host a crucial session on the global acceptance of in silico evidence in regulatory submissions. This discussion will cover the current landscape and key initiatives to advance the use of knowledge-based and data-driven models.
Highlights include:
- Engagement with regulatory authorities
- Publishing influential position papers
- Participation in global and regional initiatives
- Developing international standards
This session is essential for professionals across the product life cycle of medical devices and pharmaceuticals, offering insights on integrating in silico tools into regulatory strategies.
Stay tuned for more details on this important session at AAD 2024!
About the AAD 2024
Online Registration
